Janus Henderson Group Plc - Mar 31, 2025 SCHEDULE 13G/A Report for AVADEL PHARMACEUTICALS PLC Common Stock (AVDL)

Filing Manager
JANUS HENDERSON GROUP PLC
Reporting Manager
JANUS HENDERSON GROUP PLC
Security
AVADEL PHARMACEUTICALS PLC Common Stock
Symbol
AVDL
Shares outstanding
96.4M shares
Disclosed Ownership
13.6M shares
Ownership
14.1%
Form type
SCHEDULE 13G/A
Date filed
5/14/2025, 12:00 PM
Date of event
Mar 31, 2025
Previous filing
Feb 14, 2025
Next filing
Aug 14, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JANUS HENDERSON GROUP PLC 14.1% 13.6M 0 13.6M Kristin Mariani Head of North America Compliance, CCO
Janus Henderson Biotech Innovation Master Fund Ltd 5.4% 5.22M 0 5.22M Kristin Mariani Head of North America Compliance, CCO